ArticleFrontiers in oncology2021

Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.

Sungchan Gwark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.